Good long-term cancer-specific outcome is possible in well-selected prostate cancer patients found to have lymph node-positive disease at radical prostatectomy, findings from analyses based on 30 years of experience at a single institution demonstrate.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.